Metabolic activation of temozolomide measured in vivo using positron emission tomography

Cancer Research

Volumn 63, Issue 10, 2003, Pages 2409-2415

  Saleem, Azeem ^a   Brown, Gavin D ^a   Brady, Frank ^b   Aboagye, Eric O ^a   Osman, Safiye ^b   Luthra, Sajinder K ^b   Ranicar, Alex S O ^b   Brock, Cathryn S ^a   Stevens, Malcolm F G ^c   Newlands, Edward ^d   Jones, Terry ^b   Price, Pat ^a,e  

^a IMPERIAL CANCER RESEARCH FUND   (United Kingdom)

^b HAMMERSMITH HOSPITAL   (United Kingdom)

^c UNIVERSITY OF NOTTINGHAM   (United Kingdom)

^d CHARING CROSS HOSPITAL   (United Kingdom)

^e CHRISTIE HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ALKYLATING AGENT; ANTINEOPLASTIC AGENT; BICARBONATE; CARBON 11; CARBON DIOXIDE; DNA; TEMOZOLOMIDE;

ADULT; AREA UNDER THE CURVE; ARTICLE; BRAIN TUMOR; CLINICAL ARTICLE; DRUG MECHANISM; DRUG METABOLISM; DRUG TARGETING; GLIOMA; HUMAN; INJECTION; ISOTOPE LABELING; MALE; METABOLITE; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; TISSUE DISTRIBUTION;

ADULT; AGED; ANTINEOPLASTIC AGENTS, ALKYLATING; BIOTRANSFORMATION; BRAIN NEOPLASMS; CARBON DIOXIDE; CARBON RADIOISOTOPES; DACARBAZINE; GLIOMA; HUMANS; MALE; MIDDLE AGED; TOMOGRAPHY, EMISSION-COMPUTED;

EID: 0038520096     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (26)

1. Stevens, M. F., Hickman, J. A., Stone, R., Gibson, N. W., Baig, G. U., Lunt, E., and Newton, C. G. Antitumor imidazotetrazines. 1. Synthesis and chemistry of 8-carbamoyl-3-(2-chloroethyl)imidazo[5, 1-d]-1, 2, 3, 5-tetrazin-4(3 H)-one, a novel broad-spectrum antitumor agent. J. Med. Chem., 27: 196-201, 1984.
2. Newlands, E. S., Blackledge, G. R., Slack, J. A., Rustin, G. J., Smith, D. B., Stuart, N. S., Quarterman, C. P., Hoffman, R., Stevens, M. F., Brampton, M. H., and Gibson, A. C. Phase I trial of temozolomide (CCRG 81045: M&B 39831: NSC 362856). Br. J. Cancer, 65: 287-291, 1992.
3. Baker, S. D., Wirth, M., Statkevich, P., Reidenberg, P., Alton, K., Sartorius, S. E., Dugan, M., Cutler, D., Batra, V., Grochow, L. B., Donehower, R. C., and Rowinsky, E. K. Absorption, metabolism, and excretion of 14C-temozolomide following oral administration to patients with advanced cancer. Clin. Cancer Res., 5: 309-317, 1999.
4. Newlands, E. S., Stevens, M. F., Wedge, S. R., Wheelhouse, R. T., and Brock, C. Temozolomide: a review of its discovery, chemical properties, pre- clinical development and clinical trials. Cancer Treat. Rev., 23: 35-61, 1997.
5. Clark, A. S., Deans, B., Stevens, M. F. G., Tisdale, M. J., Wheelhouse, R. T., Denny, B. J., and Hartley, J. A. Antitumor imidazotetrazines. 32. Synthesis of novel imidazotetrazinones and related bicyclic heterocycles to probe the mode of action of the antitumor drug temozolomide. J. Med. Chem., 38: 1493-504, 1995.
6. Denny, B. J., Wheelhouse, R. T., Stevens, M. F., Tsang, L. L., and Slack, J. A. NMR and molecular modeling investigation of the mechanism of activation of the antitumor drug temozolomide and its interaction with DNA. Biochemistry, 33: 9045-9051, 1994.
7. Saleem, A., Yap, J., Osman, S., Brady, F., Suttle, B., Lucus, S. V., Jones, T., Price, P. M., and Aboagye, E. O. Modulation of fluorouracil tissue pharmacokinetics by eniluracil: in-vivo imaging of drug action. Lancet, 355: 2125-2131, 2000.
8. Saleem, A., Harte, R. J., Matthews, J. C., Osman, S., Brady, F., Luthra, S. K., Brown, G. D., Bleehen, N., Connors, T., Jones, T., Price, P. M., and Aboagye, E. O. Pharmacokinetic evaluation of N-[2-dimethylamino)ethyl]acridine-4-carboxamide in patients by positron emission tomography. J. Clin. Oncol., 19: 1421-1429, 2001.
9. Spinks, T. J., Jones, T., Bailey, D. L., Townsend, D. W., Grootoonk, S., Bloomfield, P. M., Gilardi, M. C., Casey, M. E., Sipe, B., and Reed, J. Physical performance of a positron tomograph for brain imaging with retractable septa. Phys. Med. Biol., 37: 1637-1655, 1992.
10. Brown, G. D., Turton, D. R., Luthra, S. K., Price, P., Jones, T., Stevens, M. F. G., Baghurst, D. R., Mingos, D. M. P., Osman, S., Water, S. L., and Brady, F. Synthesis of [11C-methyl]methylisocyanate and application of microwave heating to labelling the novel anticancer agent Temozolomide. J. Label Cmpd. Radiopharm., 35: 100-103, 1994.
11. Brown, G. D., Brady, F., Luthra, S. K., Prenant, C., Stevens, M. F. G., Sergis, A., and Price, P. An improved radiosynthesis of 4-[11C-carbonyl]temozolomide using [11C carbonyl]methylisocyanate. J. Label Cmpd. Radiopharm., 40: 371, 1997.
12. Shields, A. F., Graham, M. M., Kozawa, S. M., Kozell, L. B., Link, J. M., Swenson, E. R., Spence, A. M., Bassingthwaighte, J. B., and Krohn, K. A. Contribution of labeled carbon dioxide to PET imaging of carbon-11-labeled compounds. J. Nucl. Med., 33: 581-584, 1992.
13. Brooks, R. A., and Di Chiro, G. Theory of image reconstruction in computed tomography. Radiology, 117: 561-572, 1975.
14. Harte, R. J., Matthews, J. C., O'Reilly, S. M., Tilsley, D. W., Osman, S., Brown, G., Luthra, S. J., Brady, F., Jones, T., and Price, P. M. Tumor, normal tissue, and plasma pharmacokinetic studies of fluorouracil biomodulation with N-phosphonacetyl-L-aspartate, folinic acid, and interferon α. J. Clin. Oncol., 17: 1580-1588, 1999.
15. Cunningham, V. J., and Jones, T. Spectral analysis of dynamic PET studies. J. Cereb. Blood Flow Metab., 13: 15-23, 1993.
16. Gunn, R. N., Yap, J. T., Wells, P, Osman, S., Price, P., Jones, T., and Cunningham, V. J. A general method to correct PET data for tissue metabolites using a dual-scan approach. J. Nucl. Med., 41: 706-711, 2000.
17. Meikle, S. R., Matthews, J. C., Brock, C. S., Wells, P., Harte, R. J., Cunningham, V. J., Jones, T., and Price, P. Pharmacokinetic assessment of novel anti-cancer drugs using spectral analysis and positron emission tomography: a feasibility study. Cancer Chemother. Pharmacol., 42: 183-193, 1998.
18. Aboagye, E. O., Saleem, A., Cunningham, V. J., Osman, S., and Price, P. M. Extraction of 5-fluorouracil by tumor and liver: a noninvasive positron emission tomography study of patients with gastrointestinal cancer. Cancer Res., 61: 4937-4941, 2001.
19. Gunn, R. N., Ranicar, A., Yap, T. J., Wells, P., Osman, S., Jones, T., and Cunningham, V. J. On-line measurement of exhaled [11C]CO2 during PET. J. Nucl. Med., 41: 605-611, 2000.
20. Stevens, M. F., Hickman, J. A., Langdon, S. P., Chubb, D., Vickers, L., Stone, R., Baig, G., Goddard, C., Gibson, N. W., and Slack, J. A. Antitumor activity and pharmacokinetics in mice of 8-carbamoyl-3-methyl-imidazo[5, 1-d]-1, 2, 3, 5-tetrazin-4(3H)-one (CCRG 81045; M & B 39831), a novel drug with potential as an alternative to dacarbazine. Cancer Res., 47: 5846-5852, 1987.
21. Tsang, L. L., Quarterman, C. P., Gescher, A., and Slack, J. A. Comparison of the cytotoxicity in vitro of temozolomide and dacarbazine, prodrugs of 3-methyl-(triazen-1-yl)imidazole-4-carboxamide. Cancer Chemother. Pharmacol., 27: 342-346, 1991.
22. Bleehen, N. M., Newlands, E. S., Lee, S. M., Thatcher, N., Selby, P., Calvert, A. H., Rustin, G. J., Brampton, M., and Stevens. M. F. Cancer research campaign phase II trial of temozolomide in metastatic melanoma. J. Clin. Oncol., 13: 13, 910-913, 1995.
23. Newlands, E. S., O'Reilly, S. M., Glaser, M. G., Bower, M., Evans, H., Brock, C., Brampton, M. H., Colquhoun, I., Lewis, P., Rice-Edwards, J. M., Illingworth, R. D., and Richards, P. G. The Charing Cross Hospital experience with temozolomide in patients with gliomas. Eur. J. Cancer, 32A: 2236-2241, 1996.
24. Hartley, J. A., Mattes, W. B., Vaughan, K., and Gibson, N. W. DNA sequence specificity of guanine N7-alkylations for a series of structurally related triazenes. Carcinogenesis (Lond.), 9: 669-674, 1988.
25. Baer, J. C., Freeman, A. A., Newlands, E. S., Watson, A. J., Rafferty, J. A., and Margison, G. P. Depletion of O6-alkylguanine-DNA alkyltransferase correlates with potentiation of temozolomide and CCNU toxicity in human tumour cells. Br. J. Cancer, 67: 1299-302, 1993.
26. Tisdale, M. J. Antitumor imidazotetrazines-XV. Role of guanine O6 alkylation in the mechanism of cytotoxicity of imidazotetrazinones. Biochem. Pharmacol., 36: 457-462, 1987.